NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
24.63
-0.14 (-0.57%)
At close: 4:00PM EST

24.63 0.00 (0.00%)
After hours: 4:29PM EST

Stock chart is not supported by your current browser
Previous Close24.77
Open24.88
Bid24.50 x 100
Ask27.90 x 4000
Day's Range24.61 - 25.07
52 Week Range20.45 - 30.80
Volume252,275
Avg. Volume491,508
Market Cap1.631B
Beta0.08
PE Ratio (TTM)N/A
EPS (TTM)-0.21
Earnings DateNov 1, 2017 - Nov 6, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.88
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit7 days ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting NXTM. Over the last one-month, outflows of investor capital in ETFs holding NXTM totaled $3.72 billion.

  • Capital Cube21 days ago

    ETFs with exposure to NxStage Medical, Inc. : December 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
    Capital Cube22 days ago

    NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017

    Categories: Yahoo FinanceGet free summary analysis NxStage Medical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of NxStage Medical, Inc. – Rockwell Medical, Inc., Fresenius Medical Care AG & Co. KGaA Sponsored ADR, Cantel Medical Corp., C. R. Bard, Inc., Baxter International Inc., Nephros, Inc., ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit25 days ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • NxStage Nx2me Connected Health Improves Home Hemodialysis
    Zackslast month

    NxStage Nx2me Connected Health Improves Home Hemodialysis

    NxStage Medical (NXTM) consistently looks to expand dialysis platform.

  • PR Newswirelast month

    NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants

    "The more I realize how things have changed for the better, the more amazed I am," said Maria Jimenez, a former NxStage patient. "Switching from in-center to home hemodialysis with NxStage System One was life-changing for me. Soon after I started dialyzing more often at home, I noticed I felt better and had more energy.  I am extremely thankful for everything home hemodialysis has given me, and I know more frequent treatments got me where I am today.

  • NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants
    CNW Grouplast month

    NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants

    NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants

  • Nx2me Connected Health® Improves Home Hemodialysis Retention
    PR Newswirelast month

    Nx2me Connected Health® Improves Home Hemodialysis Retention

    In the study, outcomes among 606 Nx2me users and contemporary matched controls were compared.1 Nx2me users comprised both patients already established on home hemodialysis with the NxStage System One and new home hemodialysis patients. A key component of the Nx2me platform is the Nx2me iPad® app, which is designed to increase patients' ease of use of home therapy by capturing treatment data and wirelessly sending it to their center after each treatment, thereby reducing the need for paper flow sheets.

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • Reuters2 months ago

    Prospect of tougher antitrust regulation worries deal investors

    The top U.S. antitrust regulator has sent a chilling message to dealmakers with his opposition to AT&T Inc buying Time Warner Inc: Companies do not have to be competitors for their merger to hurt competition, and there are no simple fixes to get such deals approved. The Department of Justice's lawsuit to block the AT&T purchase could be a negative sign for other so-called "vertical" mergers - where the companies do not compete but one supplies the other - such as pharmacy operator CVS Health Corp's plan to buy insurer Aetna Inc. Investors had thought AT&T's acquisition of Time Warner, if not a slam dunk, would be approved by the Justice Department and its antitrust division chief Makan Delrahim with relatively few asset sales or conditions.

  • NxStage Medical Prepares for Fresenius Merger
    Motley Fool2 months ago

    NxStage Medical Prepares for Fresenius Merger

    Find out how the dialysis specialist's business fared in the shadow of a buyout bid.

  • Capital Cube2 months ago

    ETFs with exposure to NxStage Medical, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Eleven Unique NxStage Abstracts Accepted for 2017 Kidney Week
    PR Newswire2 months ago

    Eleven Unique NxStage Abstracts Accepted for 2017 Kidney Week

    New studies being showcased at the American Society of Nephrology Congress confirm interim results from FREEDOM study and present new data on therapy retention and graduation rates. LAWRENCE, Mass., Nov. 1, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new findings in a series of compelling research abstracts demonstrating, and further validating, the importance of more frequent home hemodialysis.

  • Capital Cube3 months ago

    ETFs with exposure to NxStage Medical, Inc. : October 23, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NxStage Announces Winners of Third Annual Nurse Hero Award
    PR Newswire3 months ago

    NxStage Announces Winners of Third Annual Nurse Hero Award

    LAWRENCE, Mass., Oct. 18, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NXTM), a leading medical technology company focused on advancing renal care, today announced Dawn Meade as the national winner of the third annual Nurse Hero Award. The Nurse Hero Award was designed to recognize the important role home hemodialysis (HHD) nurses play in helping patients to receive access to this life-changing dialysis therapy. "NxStage congratulates Dawn and all of the other nominees on being recognized by their patients and peers for their commitment to providing extraordinary patient care," said NxStage President, Joe Turk.

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit3 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • Capital Cube3 months ago

    ETFs with exposure to NxStage Medical, Inc. : October 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube3 months ago

    NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis NxStage Medical, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of NxStage Medical, Inc. – Cantel Medical Corp. (CMD-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 96.22 million, Net Earnings of USD -2.09 ... Read more (Read more...)

  • NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : October 6, 2017
    Capital Cube3 months ago

    NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : October 6, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for NxStage Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit3 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • PR Newswire3 months ago

    Jeffrey H. Burbank Joins CryoLife Board of Directors

    ATLANTA , Oct. 2, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey ...

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit4 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • PR Newswire4 months ago

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Nxstage Medical, Inc. - NXTM

    NEW YORK , Sept. 10, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...

  • NxStage System One Gets FDA Nod for Solo Home Hemodialysis
    Zacks5 months ago

    NxStage System One Gets FDA Nod for Solo Home Hemodialysis

    The latest regulatory go-ahead is likely to lend NxStage (NXTM) a competitive edge and expand its patient base with solid access to the clinical benefits associated with home hemodialysis.